Science Explorer Back to mapMap
Discussion
Researcher · Centro de Genética Clínica · Portugal

Fátima Torres

Fátima Torres publishes mostly in Genetics, Hematology and Cardiology and Cardiovascular Medicine, on topics such as Genomic variations and chromosomal abnormalities, Genetics and Neurodevelopmental Disorders and Acute Myeloid Leukemia Research.

OpenAlex
World rank
#4,718,144
of 7,710,434 ranked researchers
Rank in Portugal
#24,083
of 41,760
Works
21
Citations
338
Citations per work
16.1
h-index
9
i10-index 9Top 69% in Genetics (Biochemistry, Genetics and Molecular Biology)
Fátima Torres

What does Fátima Torres research?

Fátima Torres's work is mostly in Medicine (33%), Biochemistry, Genetics and Molecular Biology (23%), Immunology and Microbiology (6%).

Everything else: 8 works · 38.3% of their workHealth Sciences: 7 works · 32.8% of their workMedicine: 7 works · 32.8% of their workHematology: 3 works · 13.5% of their workCardiology and Cardiovascular Medicine: 2 works · 7.7% of their workGenetics: 1 works · 5.8% of their workOncology: 1 works · 5.8% of their workLife Sciences: 6 works · 28.9% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 23.1% of their workGenetics: 5 works · 23.1% of their workImmunology and Microbiology: 1 works · 5.8% of their workImmunology: 1 works · 5.8% of their workTHEIR WORKFátima Torres21works
Life Sciences29%Health Sciences33%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else838.3%
    1. Medicine732.8%
    1. Biochemistry, Genetics and Molecular Biology523.1%
    2. Immunology and Microbiology15.8%
  1. 1Genetics23% of their works
  2. 2Hematology14% of their works
  3. 3Cardiology and Cardiovascular Medicine8% of their works
  4. 4Oncology6% of their works
  5. 5Genetics6% of their works
  6. 6Immunology6% of their works

Research topics

Which keywords describe Fátima Torres's research?

The keywords of their largest research topics: Prognostic Factors, Copy Number Variation, Genomic Rearrangements, Acute Myeloid Leukemia, AML, Fragile X Syndrome, Rett Syndrome and BCR-ABL.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Prognostic Factors62 topics
  2. Copy Number Variation51 topic
  3. Genomic Rearrangements51 topic
  4. AML41 topic
  5. Acute Myeloid Leukemia41 topic
  6. Fragile X Syndrome41 topic
  7. Rett Syndrome41 topic
  8. BCR-ABL31 topic
  9. Imatinib31 topic
  10. Chronic Lymphocytic Leukemia21 topic
  11. Diagnosis21 topic
  12. Genetic Variants21 topic
  13. Genome Evolution21 topic
  14. Genomic Aberrations21 topic
  15. Infective Endocarditis21 topic
  16. Polyploidy21 topic
  17. Sequence Interpretation21 topic

Where does Fátima Torres work?

Fátima Torres's main affiliation in the publication record is Centro de Genética Clínica, Portugal.

How many publications and citations does Fátima Torres have?

OpenAlex counts 21 works and 338 citations for Fátima Torres, an h-index of 9, ranking #4,718,144 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Fátima Torres. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.